Processed meat and gastric cancer: the 30-gram threshold the EPIC cohort just hardened

TL;DR

• A new EPIC cohort analysis (n = 450,112, 14.1 years follow-up) published in the International Journal of Cancer finds that every extra 30 g of processed meat per day — about one slice of ham — is associated with a 9% higher risk of gastric cancer and a 13% higher risk of esophageal adenocarcinoma.
• Each extra 20 g of white meat (chicken, turkey) was associated with a 12% higher risk of non-cardia gastric cancer. That is the new and unsettling part.
• Sex differences: in men, only processed meat was linked to gastric cancer. In women, both processed and white meat were.
• This is a confirmatory cohort, not a randomised trial. But 450,000 people across ten European countries followed for 14 years is about as strong as nutritional epidemiology gets.
• The actionable takeaway is unchanged but sharper: regular processed meat raises risk in a dose-response way. The number to remember is 30 g/day.

The number

The headline figure is 30 grams. One slice of supermarket ham. Half a chorizo sausage. One rasher of streaky bacon.

For each 30 g/day increment in processed meat consumption, gastric cancer risk rose by 9% (95% CI 2–17) and esophageal adenocarcinoma risk rose by 13% (95% CI 0–27). The confidence interval on the EAC figure brushes zero, which is honest reporting territory — the effect is real but the lower bound is thin. The gastric cancer figure is clean.

For context, the average UK adult eats roughly 50 g/day of processed meat. The average French adult is similar. American averages run higher.

What's actually new

The processed-meat-and-cancer story has been told since the IARC's October 2015 classification of processed meat as Group 1 carcinogenic to humans. So why is this paper worth a Friday read?

Three reasons:

1. The cohort. EPIC — the European Prospective Investigation into Cancer and Nutrition — is the largest prospective nutrition cohort in the world. 450,000 people, ten countries, calibrated food-frequency questionnaires, validated cancer registry follow-up. Earlier EPIC papers used shorter follow-ups and fewer endpoints. This one has 14.1 years and 876 gastric cancer cases plus 215 esophageal adenocarcinomas, which is enough statistical power to split by anatomical site (cardia vs. non-cardia) and histological type.

2. The processed meat / EAC result. Earlier large cohorts — including the NIH-AARP study — could not robustly tie processed meat to esophageal adenocarcinoma. EPIC now can. EAC is the rapidly-rising cancer of the lower esophagus, the type most strongly linked to acid reflux and obesity. Adding a dietary driver matters because it is one of the few cancers whose incidence has been climbing in Western countries for thirty years.

3. The white-meat finding. "White meat is safer" has been the standard advice for two decades. The EPIC team observed a 12% per-20g/day increase in non-cardia gastric cancer risk associated with white meat intake, especially in women. This is one cohort and the mechanism is unclear — possibly cooking method (high-temperature grilling produces heterocyclic amines regardless of meat colour), possibly an indicator of broader dietary pattern. It is not yet enough to swap chicken for tofu on. It is enough to stop saying "switch to white meat" as if the question were settled.

Where the numbers stop agreeing

The standard objections to nutritional cohort epidemiology all apply here.

• Confounding. People who eat a lot of processed meat differ from people who don't in dozens of measurable ways and probably more unmeasurable ones — smoking, alcohol, fibre intake, BMI, H. pylori exposure, socioeconomic status. EPIC adjusts heavily but cannot adjust completely.
• Measurement error. Food-frequency questionnaires are imperfect. People misremember and misreport. EPIC's calibration sub-study mitigates but does not eliminate this.
• Absolute risk. A 9% relative increase from a low baseline is still a low number. Lifetime gastric cancer risk in Europe is roughly 1.1%. A 9% relative increase per 30 g/day on top of that is real but is not, on its own, the scariest thing on the supermarket shelf.

The picture this paper paints is not "processed meat causes a cancer epidemic." It is "processed meat is a real, dose-dependent, modest contributor to upper gastrointestinal cancer, with an effect size consistent with WHO/IARC's existing classification."

What this isn't

It is not a finding that you should never eat ham. It is not a finding that white meat is dangerous. It is not a finding that the Mediterranean diet was wrong — the Mediterranean dietary pattern in EPIC, with low processed meat and moderate poultry, performed as expected on the protective side. And it is not a finding that vegetarian diets are clearly superior to mixed diets — that comparison was not the question.

It is, fundamentally, a confirmation paper. The bigger story is the white-meat signal that nobody quite knows what to do with yet.

Cross-layer implications

• Public health. The 30 g/day threshold deserves to enter dietary guidelines as a soft cap, not just a warning. Several European countries (Netherlands, Denmark) already have this. The UK's 70 g/day NHS guidance now looks generous given the EPIC dose-response.
• Food industry. Nitrate/nitrite-reduced processed meats are scientifically interesting but commercially marginal. EPIC does not distinguish them, so the data cannot yet tell you whether "uncured" bacon clears the risk or just shifts the chemistry.
• Cancer screening. EAC incidence has been climbing for decades and current screening is poor. Risk-stratified Barrett's surveillance protocols may need to weight dietary processed meat more than they currently do.
• Australia specifically. Per-capita processed meat intake here sits around 50 g/day — well above the 30 g threshold. The Cancer Council's advice has been broadly correct; this paper sharpens the dose-response argument behind it.

What to do about it

Addressed to the general public — anyone making weekly food decisions.

The action is small, boring, and effective:

• Cap processed meat at roughly one slice of ham, or one rasher of bacon, per day on average. Below 30 g/day is the evidence-supported zone.
• Don't treat "switch to chicken" as a complete answer. The white-meat finding does not justify cutting poultry out, but it argues for cooking method (avoid heavy charring), portion size, and dietary diversity rather than the white-meat-as-shield framing.
• Vegetables, legumes, whole grains, fish, fermented dairy. EPIC and every other major cohort converge on this. The headlines change; the food does not.
• If you have a family history of upper-GI cancer, or H. pylori infection history, talk to your GP about Barrett's and gastric surveillance. The processed-meat effect is amplified in higher-baseline-risk groups.

Uncertainty ledger

• The white-meat result needs replication in non-European cohorts before "eat less chicken" becomes a defensible message. It almost certainly is not, yet.
• The processed-meat / EAC confidence interval is wide. Replication will narrow it.
• Cooking-method effects (grilling, charring, smoking) are not separated cleanly from the meat-type signal. Future EPIC analyses are expected to address this.
• The cohort is European. Asian, African, and Latin American gastric cancer epidemiology has a different baseline (much higher H. pylori prevalence, different cooking traditions) and the dose-response may not transfer cleanly.

Bottom Line

The 2015 IARC call on processed meat was the right call, and a new analysis of 450,000 Europeans followed for fourteen years has just dose-stamped it: roughly 30 grams a day is where the gastric and esophageal cancer signal becomes hard to argue with. The Mediterranean dietary pattern remains the strongest evidence-based answer. The white-meat finding is interesting, narrow, and not yet a reason to change anyone's lunch.

Sources

• International Journal of Cancer, 2026 — EPIC cohort analysis of meat intake and gastric/esophageal adenocarcinoma. Tier 1.
• French National Cancer Institute, Nota Bene Cancer Bulletin 685, 26 May 2026 — summary and effect-size verification. Tier 1.
• Fox News Health, 3 June 2026 — press reporting. Tier 3.
• IARC Monograph 114 (2015) and prior EPIC publications — background classification. Tier 1.